Barely Significant
← all phrases

“an increasing trend”

63,972 sentences · 63,972 papers · 107,686 search hits before verification · confirmed specimen

Sighted at

p<0.09

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

an increasing trendp > .051.0× alphagold
Honey treatment leads to a decreasing trend in the contents of inhibitory neurotransmitter VIP and 5‐HT, and an increasing trend in the expression of excitatory neurotransmitter SP (all p > .05). 3.3 Honey re‐established the equilibrium of intestinal microecosystem The modulatory effect of honey on the intestinal microbiota was investigated by sequencing of the V3‐V4 region of the 16S rRNA gene of the predominant bacteria in mice.
an increasing trendP < 0.051.0× alphagold
Effects of Dietary Allicin on Antioxidant and Innate Immunity Capacity of Fish Larvae The activity of T-AOC showed an increasing trend with increasing dietary allicin, and larvae fed diets with 0.005, 0.01, and 0.02% allicin was significantly higher than the control group ( P < 0.05) ( Figure 2A ).
an increasing trendp < 0.051.0× alphagold
In general, the EGCG3′′Me contents showed an increasing trend with the leaf maturity from the bud and first leaf to the sixth leaf to a certain extent, and the content of EGCG3′′Me in the bud and first leaf was lower (p < 0.05) than that of other parts of the tea shoots, whereas EGCG, ECG, and TC levels in the different stages of leaf maturity presented a reverse trend.
an increasing trendP > 0.051.0× alphagold
Although there was an increasing trend of β, the difference was not statistically significant (P > 0.05), while the FGF1-nlip+UTMD group A, β, and A×β were significantly increased (P < 0.05); compared with the FGF1 solution group and FGF1-nlip group, the FGF1-nlip+UTMD group A and A × β were significantly increased (P < 0.05), and β increased slightly (P > 0.05) ( Table 3 ).
an increasing trendp < 0.051.0× alphagold
MUC16 expression in pre and post-treatment groups using both drugs (methotrexate and cisplatin) was up-regulated and displayed an increasing trend in the placebo (4.31–5.11%), AF(D)NMs (6.13–6.36%) and IV-drug groups (7.67–8.14%) ( p < 0.05), whilst in the NMs (D) group, MUC16 expression was down-regulated (2.67–3.3%) ( Figure 11 ).